Grove Collaborative Holdings, Inc. (GROV)

NYSE: GROV · Real-Time Price · USD

1.380

-0.020 (-1.43%)

At close: Aug 1, 2025, 4:00 PM

1.380

0.00 (0.00%)

After-hours: Aug 1, 2025, 7:00 PM EDT

CTI BioPharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for CTI BioPharma stock has a target of 1.20, which predicts a -13.04% decrease from the current stock price of 1.38.

Price Target: $1.20 (-13.04%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.20	$1.20	$1.20	$1.20
Change	-13.04%	-13.04%	-13.04%	-13.04%

Analyst Ratings

According to 1 stock analyst, the rating for CTI BioPharma is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	0	0	0
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dana Telsey Telsey Advisory Group	Telsey Advisory Group	Hold Maintains $1.2	Hold	Maintains	$1.2	-13.04%	Jul 14, 2025
Dana Telsey Telsey Advisory Group	Telsey Advisory Group	Buy → Hold Downgrades $2 → $1.2	Buy → Hold	Downgrades	$2 → $1.2	-13.04%	May 15, 2025
Dana Telsey Telsey Advisory Group	Telsey Advisory Group	Buy Maintains $2	Buy	Maintains	$2	+44.93%	May 8, 2025
Dana Telsey Telsey Advisory Group	Telsey Advisory Group	Buy Maintains $2	Buy	Maintains	$2	+44.93%	Mar 12, 2025
Dana Telsey Telsey Advisory Group	Telsey Advisory Group	Buy Maintains $2	Buy	Maintains	$2	+44.93%	Mar 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

187.65M

from 203.43M

-7.75%

from 203.43M

Revenue Next Year

199.32M

from 187.65M

6.22%

from 187.65M

EPS This Year

-0.51

from -0.76

EPS Next Year

-0.38

from -0.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	364.27M	383.69M	321.53M	259.28M	203.43M	187.65M	199.32M
Revenue Growth	56.26%	5.33%	-16.20%	-19.36%	-21.54%	-7.75%	6.22%
EPS	-67.25	-79.28	-4.85	-1.28	-0.76	-0.51	-0.38
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	193.2M	212.4M
Avg	187.7M	199.3M
Low	180.3M	184.7M

Revenue Growth

Revenue Growth	2025	2026
High	-5.0%	13.2%
Avg	-7.8%	6.2%
Low	-11.4%	-1.6%

EPS Forecast

EPS	2025	2026
High	-0.53	-0.39
Avg	-0.51	-0.38
Low	-0.49	-0.36

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.